Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Related Neutropenia in Patients with Non-Hodgkin's Lymphomas—A Phase I/II Study of Dose and Mode of Administration

References

• De Jongh C. A., Schimpff S. C. Bacterial infections in neutropenic patients in supportive care. Cancer Therapy, D. J. Higby. Nijhoff, Dordrect, The Netherlands 1983; 1–14
   Google Scholar
• Metcalf D. The granulocyte-macrophage colony-stimulating factors. Science 1985; 229: 16–22
   PubMed Web of Science ®Google Scholar
• Clark S. C., Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229–1237
   PubMed Web of Science ®Google Scholar
• Grabstein K. H., Urdal D. L., Tuschinski R. J. Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science 1986; 232: 506–508
   PubMed Web of Science ®Google Scholar
• Weisbart R. H., Golde D. W., Clark S. C. Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature 1985; 314: 361–363
   PubMed Web of Science ®Google Scholar
• Fleischmann J., Golde D. W., Weisbart R. H. Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood 1986; 68: 708–711
   PubMed Web of Science ®Google Scholar
• Metcalf D., Begley C. G., Johnson G. R. Biologic properties in vitro of recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1986; 67: 37–45
   PubMed Web of Science ®Google Scholar
• Lopez A. F., Williamson D. J., Gamble J. R. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest 1986; 78: 1220–1228
   PubMed Web of Science ®Google Scholar
• Wong G. G., Witek J. S., Temple P. A. Human GM-CSF: Molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 1985; 228: 810–815
   PubMed Web of Science ®Google Scholar
• Cantrell M. A., Anderson D., Ceretti D. P. Cloning, sequence, and expression of a human granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci USA 1985; 82: 6250–6254
   PubMed Web of Science ®Google Scholar
• Butturini A., Gale R. P., Lopes D. M. Use of recombinant granulocyte-macrophage colony-stimulating factor in the Brazil radiation accident. Lancet 1988; 27: 471–475
   Google Scholar
• Neumanaitis J., Singer J. W., Buckner C. D. Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Blood 1988; 72: 834–836
   PubMed Web of Science ®Google Scholar
• Groopman J. E., Mitsuyasu R. T., Deleo M. J., Oette D. H., Golde D. W. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in acquired immunodeficiency syndrome. N Engl J Med 1987; 317: 593–598
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S., Keating M., Lemaistre A. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med 1987; 317: 1545–1552
   PubMed Web of Science ®Google Scholar
• Brandt S. J., Peters W.P., Atwater S. K. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 1988; 318: 869–875
   PubMed Web of Science ®Google Scholar
• Antin J. H., Smith B. R., Holmes W., Rosenthal D. S. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood 1988; 72: 705–713
   PubMed Web of Science ®Google Scholar
• Antmann K. S., Griffin J. D., Elias A. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 1988; 319: 593–598
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S., Buescher S., Lemaistre A. Stimulation of Hematopoiesis in Patients with Bone Marrow Failure and in Patients with Malignancy by Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor. Blood 1988; 72: 134–141
   PubMed Web of Science ®Google Scholar
• Steward W. P., Scharffe J. H., Austin R. Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given daily as short infusion—a phase 1 dose-toxicity study. Br J Cancer 1989; 59: 142–145
   PubMed Web of Science ®Google Scholar
• Philips N., Jacobs S., Stoller R., Earle M., Przepiorka D., Shadduck R. K. Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Myelopoiesis in Patients With Refractory Metastatic Carcinoma. Blood 1989; 74: 26–34
   PubMed Web of Science ®Google Scholar
• Logothetis C. J., Dexeus F. H., Sella A. trexate-Vinblastine-Doxorubicin-Cisplatin Plus Unglycosylated Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor. J Natl Cancer Inst 1990; 82: 667–672
   PubMed Web of Science ®Google Scholar
• Kharazmi A., Nielsen H., Hovgaard D., Borregaard N., Nissen N. I. Modulation of neutrophil and monocyte function by recombinant human granuloycte-macrophage colony-stimulating factor in patients with lymphomas. Eur J Clin Invest 1991; 21: 219–224
   PubMed Web of Science ®Google Scholar
• Hovgaard D., Mortensen B. T., Shifter S., Nissen N. I. Clinical pharmacokinetic studies of a human hemopoietic growth factor, GM-CSF. Eur J. Clin Invest, in press
   Google Scholar
• Lieschke G. J., Maher D., O'Connor M. Phase I Study of Intravenously Administered Bacterially Synthesized Granulocyte-Macrophage Colony-Stimulating Factor and Comparison with Subcutaneous Administration. Cancer Res 1990; 50: 606–614
   PubMed Web of Science ®Google Scholar
• Salmon S. E., Liu R. Effects of Granulocyte-Macrophage Colony-Stimulating Factor on In Vitro Growth of Human Solid Tumors. J Clin Oncol 1989; 7: 1346–1350
   PubMed Web of Science ®Google Scholar
• Rifkin R. M., Hersch E. M., Salmon S. E. A Phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by i.v. bolus or continuous infusion. Behring Inst. Mitt 1988; 83: 125–133
   PubMedGoogle Scholar
• Herrmann F., Schultz G., Lindemann A. Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor. J Clin Oncol 1989; 7: 159–167
   PubMed Web of Science ®Google Scholar